Direxion Daily 20+ Year Treasury Bear 3X ETF (TMV)
| Assets | $221.51M |
| Expense Ratio | 0.97% |
| PE Ratio | n/a |
| Forward PE | n/a |
| Shares Out | 4.95M |
| Dividend | $0.96 (2.10%) |
| Ex-Dividend Date | Sep 22, 2026 |
| Payout Frequency | Quarterly |
| Payout Ratio | n/a |
| Volume | 1,461,579 |
| Open | 46.20 |
| Previous Close | 45.66 |
| Day's Range | 45.18 - 46.24 |
| 52-Week Low | 31.82 |
| 52-Week High | 52.20 |
| Beta | -1.56 |
| Holdings | 9 |
| Inception Date | Apr 16, 2009 |
About TMV
Fund Home PageThe Direxion Daily 20+ Year Treasury Bear 3X ETF (TMV) is an exchange-traded fund that is based on the US Treasury 20+ Year index. The fund provides -3x daily exposure to a market-value-weighted index of US Treasury bonds with over 20 years to maturity. TMV was launched on Apr 16, 2009 and is issued by Direxion.
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 22, 2026 | $0.22652 | Sep 29, 2026 |
| Jun 23, 2026 | $0.24107 | Jun 30, 2026 |
| Mar 24, 2026 | $0.37547 | Mar 31, 2026 |
| Dec 23, 2025 | $0.11636 | Dec 31, 2025 |
| Sep 23, 2025 | $0.22872 | Sep 30, 2025 |
| Jun 24, 2025 | $0.28288 | Jul 1, 2025 |
Performance
TMV had a total return of 40.20% in the past year, including dividends. Since the fund's inception, the average annual return has been -13.56%.
News
Weave Bio Expands Strategic Advisory Board with Two Former FDA Leaders
SAN FRANCISCO--(BUSINESS WIRE)---- $TMV #AI--Weave Bio, a leader in AI-native regulatory automation for drug development, today announced the expansion of its Strategic Advisory Board (SAB) with the a...
Weave Bio Establishes Inaugural Strategic Advisory Board to Shape the Future of AI-Driven Regulatory Science
SAN FRANCISCO--(BUSINESS WIRE)---- $TMV #AIinPharma--Weave Bio, the leader in AI-native regulatory automation, today announced the formation of its inaugural Strategic Advisory Board (SAB). Bringing t...
